General Updates

Poly Medicure reported strong Q1 results for the quarter ended June 30, 2025. Consolidated revenue from operations rose to ₹403.21 Cr (up ~5% YoY), while profit after tax soared to ₹93.08 Cr (up ~25.7% YoY) from ₹74.04 Cr.

The Board appointed Mr. Pankaj Kumar Gupta as Executive Director for five years, a key move to strengthen operations.

Two independent directors were also re-appointed.

Further, 3,400 stock options were granted to eligible employees under the ESOP 2020 plan.

The company also re-appointed its Cost Auditors.